Seres Therapeutics, Inc. (MCRB)
NASDAQ·Healthcare·Biotechnology
$6.30
+5.44%
Mkt Cap $83.09M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$1.25
Range $1.25 – $1.25
Implied Upside
-80.1%
Consensus $1.25 vs current $6.30
NASDAQ·Healthcare·Biotechnology
$6.30
+5.44%
Mkt Cap $83.09M
No recent rating data.
Price Target (1 analysts)
$1.25
Range $1.25 – $1.25
-80.1%
Consensus $1.25 vs current $6.30